Comparison of results of clinicians' assessments, cytologic examination of fine-needle lymph node aspirates, and flow cytometry for determination of remission status of lymphoma in dogs

Journal of the American Veterinary Medical Association

Volumn 226, Issue 4, 2005, Pages 562-566

  Williams, Laurel E ^a   Broussard, Maia Tcheng ^a,c   Johnson, Jeffrey L ^b   Neel, Jennifer ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b DUKE CANCER INSTITUTE   (United States)

^c Animal Rehabilitation and Wellness Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASPIRATION BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CONTROLLED STUDY; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DOG; DOG DISEASE; FLOW CYTOMETRY; FOLLOW UP; LYMPH NODE BIOPSY; LYMPHOMA; NONHUMAN; PALPATION; RADIATION DOSE; TREATMENT OUTCOME;

ANIMALS; BIOPSY, FINE-NEEDLE; DOG DISEASES; DOGS; FEMALE; FLOW CYTOMETRY; LYMPH NODES; LYMPHOMA; MALE; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

ANIMALIA; CANIS FAMILIARIS;

EID: 13744254868     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2005.226.562     Document Type: Article

References (31)

1. Stone MS, Goldstein MA, Cotter SM. Comparison of two protocols for induction of remission in dogs with lymphoma. J Am Anim Hosp Assoc 1991;27:315-321.
2. Myers NC, Moore AS, Rand WM, et al. Evaluation of a multidrug combination chemotherapy protocol (ACOPA II) in dogs with lymphoma. J Vet Intern Med 1997;11:333-339.
3. Zemann BI, Moore AS, Rand WM, et al. A combination chemotherapy protocol (VELCAP-L) for dogs with lymphoma. J Vet Intern Med 1998;12:465-470.
4. Moore AS, Cotter SM, Rand WM, et al. Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma. J Vet Intern Med 2001;15:348-354.
5. Langenbach A, McManus PM, Hendrick MJ, et al. Sensitivity and specificity of methods of assessing the regional lymph nodes for evidence of metastasis in dogs and cats with solid tumors. J Am Vet Med Assoc 2001;218:1424-1428.
6. Williams LE, Packer RA. Association between lymph node size and metastasis in dogs with oral malignant melanoma: 100 cases (1987-2001). J Am Vet Med Assoc 2003;222:1234-1236.
7. Kardos TF, Sprague RI, Wakely PE, et al. Fine-needle aspiration biopsy of lymphoblastic lymphoma and leukemia. Cancer 1987;60:2448-2453.
8. Tani E, Liliemark J, Svedmyr E, et al. Cytomorphology and immunocytochemistry of fine needle aspirates from blastic non-Hodgkin's lymphomas. Acta Cytol 1989;33:363-371.
9. Fournel-Fleury C, Magnol JP, Bricaire P, et al. Cytohistological and immunological classification of canine malignant lymphomas: comparison with human non-Hodgkin's lymphomas. J Comp Pathol 1997;117:35-59.
10. Chernoff WG, Lampe HB, Cramer H, et al. The potential clinical impact of fine needle aspiration/flow cytometric diagnosis of malignant lymphoma. J Otolaryngol 1992;21(suppl 1):1-15.
11. Zardawi IM, Jain S, Bennett G. Flow-cytometric algorithm on fine-needle aspirates for the clinical workup of patients with lymphadenopathy. Diagn Cytopathol 1998;19:274-278.
12. Dey P, Saikia UN, Vohra H. DNA flow-cytometry on fine needle aspiration cytology of lymph node: how helpful is it? Indian J Pathol Microbiol 2000;43:127-130.
13. Pinto AE, Cabecadas J, Nobrega SD, et al. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma. Diagn Cytopathol 2003;29:194-199.
14. Zeppa P, Marino G, Troncone G, et al. Fine-needle cytology and flow cytometry immunophenotyping and subclassification of non-Hodgkin's lymphoma: a critical review of 307 cases with technical suggestions. Cancer 2004;102:55-65.
15. Keller ET, MacEwen EG, Rosenthal RC, et al. Evaluation of prognostic factors and sequential combination chemotherapy with doxorubicin for canine lymphoma. J Vet Intern Med 1993;7:289-295.
16. Garrett LD, Thamm DH, Chun R, et al. Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma. J Vet Intern Med 2002;16:704-709.
17. Armitage JO, Mauch PM, Harris NL, et al. Non-Hodgkin's lymphomas. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer principles and practice of oncology. 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2001;2275-2276.
18. Duncan JR. The lymph nodes. In: Cowell RL, Tyler RD, Meinkoth JH, eds. Diagnostic cytology and hematology of the dog and cat. 2nd ed. St Louis: Mosby Year Book Inc, 1999;97-103.
19. Ruslander DA, Beghard DH, Tompkins MB, et al. Immunophenotypic characterization of canine lymphoproliferative disorders. In Vivo 1997;11:169-172.
20. Gebhard DH, Carter PB. Identification of canine T-lymphocyte subsets with monoclonal antibodies. Vet Immunol Immunopathol 1992;33:187-199.
21. Siegal S. Nonparametric statistics. New York: McGraw-Hill Book Co, 1956;202-213.
22. Cotter SM. Treatment of lymphoma and leukemia with cyclophosphamide, vincristine, and prednisone: I. Treatment of dogs. J Am Anim Hosp Assoc 1983;19:159-165.
23. MacEwen EG, Hayes AA, Matus RE, et al. Evaluation of some prognostic factors for advanced multicentric lymphosarcoma in the dog: 147 cases (1978-1981). J Am Vet Med Assoc 1987;190:564-568.
24. Morris AH. Treatment algorithms and protocolized care. Curr Opin Crit Care 2003;9:236-240.
25. Cowan DN, Robinson JR, Jones BH, et al. Consistency of visual assessments of arch height among clinicians. Foot Ankle Int 1994;15:213-217.
26. Paietta E. How to optimize multiparameter flow cytometry for leukaemia/lymphoma diagnosis. Best Pract Res Clin Haematol 2003;16:671-683.
27. Stetler-Stevenson M. Flow cytometry in lymphoma diagnosis and prognosis: useful? Best Pract Res Clin Haematol 2003;16:583-597.
28. Gorczyca W, Weisberger J, Liu Z, et al. An approach to diagnosis of T-cell lymphoproliferative disorders by flow cytometry. Cytometry 2002;50:177-190.
29. Feldman PS, Covell JL, Kerdos TF. Lymph nodes. In: Fine needle aspiration cytology: lymph node, thyroid, & salivary gland. Chicago: ASCP Press, 1989;13-95.
30. Prasad RR, Narasimhan R, Sankaran V, et al. Fine-needle aspiration cytology in the diagnosis of superficial lymphadenopathy: an analysis of 2,418 cases. Diagn Cytopathol 1996;15:382-386.
31. Mukunyadzi P, Bardales RH, Palmer HE, et al. Tissue effects of salivary gland fine-needle aspiration. Does this procedure preclude accurate histologic diagnosis? Am J Clin Pathol 2000;114:741-745.